Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

Aaron R. Weiss, Yen Lin Chen, Thomas J. Scharschmidt, Yueh Yun Chi, Jing Tian, Jennifer O. Black, Jessica L. Davis, Julie C. Fanburg-Smith, Eduardo Zambrano, James Anderson, Robin Arens, Odion Binitie, Edwin Choy, Justin W. Davis, Andrea Hayes-Jordan, Simon C. Kao, Mark L. Kayton, Sandy Kessel, Ruth Lim, William H. MeyerLynn Million, Scott H. Okuno, Andrew Ostrenga, Marguerite T. Parisi, Daniel A. Pryma, R. Lor Randall, Mark A. Rosen, Mary Schlapkohl, Barry L. Shulkin, Ethan A. Smith, Joel I. Sorger, Stephanie Terezakis, Douglas S. Hawkins, Sheri L. Spunt, Dian Wang

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences